{"entity":{"type":"insider","cik":"0001584516","url":"/insider/0001584516","json_url":"/insider/0001584516.json","name":"Secor Alicia","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":6,"first":"2014-06-23","last":"2020-03-04","span_basis":"filed_date"},"name_variants":[{"name":"Secor Alicia","source":"filing","n_filings":6,"first_seen":"2014-06-23","last_seen":"2020-03-04"}],"transactions":[{"id":2894344,"accession":"0000899243-20-006996","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-006996","line_url":"/filing/0000899243-20-006996#line-1","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001584516","owner_name":"Secor Alicia","owner_display_name":"Secor Alicia","owner_url":"/insider/0001584516","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1296.0,"shares_display":"1,296","price_per_share":8.34,"price_display":"8.34","price_state":"stated","total_value":10808.64,"total_display":"10,808.64","total_whole":"10,809","shares_owned_after":16440.0,"shares_owned_after_display":"16,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-02","filed_date":"2020-03-04","scope":"insider"},{"id":2506218,"accession":"0000899243-20-000727","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-000727","line_url":"/filing/0000899243-20-000727#line-1","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001584516","owner_name":"Secor Alicia","owner_display_name":"Secor Alicia","owner_url":"/insider/0001584516","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1536.0,"shares_display":"1,536","price_per_share":8.53,"price_display":"8.53","price_state":"stated","total_value":13102.08,"total_display":"13,102.08","total_whole":"13,102","shares_owned_after":17736.0,"shares_owned_after_display":"17,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-03","filed_date":"2020-01-07","scope":"insider"},{"id":7857461,"accession":"0000899243-19-010609","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-010609","line_url":"/filing/0000899243-19-010609#line-1","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001584516","owner_name":"Secor Alicia","owner_display_name":"Secor Alicia","owner_url":"/insider/0001584516","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":14.2,"price_display":"14.20","price_state":"stated","total_value":12780.0,"total_display":"12,780.00","total_whole":"12,780","shares_owned_after":19272.0,"shares_owned_after_display":"19,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-13","filed_date":"2019-04-12","scope":"insider"},{"id":3303828,"accession":"0001382963-16-000232","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001382963-16-000232","line_url":"/filing/0001382963-16-000232#line-1","is_derivative":false,"issuer_cik":"0000821995","issuer_name":"JUNIPER PHARMACEUTICALS INC","issuer_ticker":"JNP","issuer_name_source":null,"issuer_url":"/issuer/0000821995","owner_cik":"0001584516","owner_name":"Secor Alicia","owner_display_name":"Secor Alicia","owner_url":"/insider/0001584516","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"common stock, par value $0.01","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.75,"price_display":"5.75","price_state":"stated","total_value":28750.0,"total_display":"28,750.00","total_whole":"28,750","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-25","filed_date":"2016-08-29","scope":"insider"},{"id":8316393,"accession":"0000899243-15-005118","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-15-005118","line_url":"/filing/0000899243-15-005118","is_derivative":false,"issuer_cik":"0001374690","issuer_name":"ZAFGEN, INC.","issuer_ticker":"ZFGN","issuer_name_source":null,"issuer_url":"/issuer/0001374690","owner_cik":"0001584516","owner_name":"Secor Alicia","owner_display_name":"Secor Alicia","owner_url":"/insider/0001584516","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26256.0,"shares_display":"26,256","price_per_share":41.05,"price_display":"41.05","price_state":"stated","total_value":1077808.8,"total_display":"1,077,808.80","total_whole":"1,077,809","shares_owned_after":1256.0,"shares_owned_after_display":"1,256","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-17","filed_date":"2015-09-21","scope":"insider","n_lines":2},{"id":7034390,"accession":"0001209191-14-043154","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-043154","line_url":"/filing/0001209191-14-043154#line-1","is_derivative":false,"issuer_cik":"0001374690","issuer_name":"ZAFGEN, INC.","issuer_ticker":"ZFGN","issuer_name_source":null,"issuer_url":"/issuer/0001374690","owner_cik":"0001584516","owner_name":"Secor Alicia","owner_display_name":"Secor Alicia","owner_url":"/insider/0001584516","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":80000.0,"total_display":"80,000.00","total_whole":"80,000","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-06-19","filed_date":"2014-06-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001351288","name":"GW PHARMACEUTICALS PLC","url":"/issuer/0001351288","role":"Director","n_filings":3,"first_seen":"2019-04-12","last_seen":"2020-03-04"},{"type":"issuer","type_label":"ISSUER","cik":"0000821995","name":"JUNIPER PHARMACEUTICALS INC","url":"/issuer/0000821995","role":"Director, Officer (President and CEO)","n_filings":1,"first_seen":"2016-08-29","last_seen":"2016-08-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001374690","name":"ZAFGEN, INC.","url":"/issuer/0001374690","role":"Officer (Chief Commercial Officer)","n_filings":2,"first_seen":"2014-06-23","last_seen":"2015-09-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001584516","retrieved_at":"2026-08-22T10:12:48+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}